Loading...

A I S T H E S I S
M E D I C A L

A Leap Forward in Postoperative Sepsis Prediction: The PRISM Study

PRISM Clinical Study Trials

Aisthesis Medical Prediction of Sepsis in Patients Undergoing Abdominal Surgery: A Prospective, Observational Clinical Study

Aisthesis Medical is at the forefront of medical innovation with its ongoing PRISM study, aimed at revolutionizing postoperative care through advanced predictive analytics. In collaboration with the Larissa University Hospital, this study underscores our commitment to improving patient outcomes and care efficiency.

The PRISM study, formally initiated on November 29th 2023, seeks to harness the power of predictive models to anticipate post-surgical complications, enhancing patient monitoring and intervention strategies. This research is particularly focused on the realm of postoperative sepsis, targeting a significant improvement in clinical outcomes.

Our approach combines cutting-edge technology with clinical expertise, aiming to develop a robust system that predicts patient trajectories post-surgery. The insights gained from this study are expected to lead to tailored patient care, reduced hospital stays, and a decrease in healthcare costs, marking a significant step forward in postoperative management.

Aisthesis Medical is dedicated to pushing the boundaries of medical research and application. The PRISM study represents just one of the many ways we are working to enhance healthcare delivery and patient care. We look forward to sharing further updates and insights as the study progresses.

For more information and to stay updated on the PRISM study, visit ClinicalTrials.gov - NCT06238180 and subscribe to our newsletter.